USANA Health Sciences, Inc. (USNA) Tops Q3 EPS by 5c, Raises FY11 Guidance
Tweet
Share
E-mailGet Alerts USNA Hot Sheet
Join SI Premium – FREE
USANA Health Sciences, Inc. (NASDAQ: USNA) reported Q3 EPS of $0.81, $0.05 better than the analyst estimate of $0.76. Revenue for the quarter came in at $143.5 million versus the consensus estimate of $142.3 million.
USANA Health Sciences, Inc. sees FY2011 EPS of $3.20-$3.25, versus prior guidance of $3.05-$3.10 and the consensus of $3.10. USANA Health Sciences, Inc. sees FY2011 revenue of $577-$581 million, versus prior guidance of $565-$575 million and the consensus of $578.03 million.
USANA Health Sciences, Inc. sees FY2011 EPS of $3.20-$3.25, versus prior guidance of $3.05-$3.10 and the consensus of $3.10. USANA Health Sciences, Inc. sees FY2011 revenue of $577-$581 million, versus prior guidance of $565-$575 million and the consensus of $578.03 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Octave Intelligence plc (OCTV) Tops Q2 EPS by 4c ; Offers Guidance
- Avino Silver & Gold Mines (ASM) Misses Q2 EPS by 4c
- Century Therapeutics, Inc. (IPSC) Misses Q2 EPS by 6c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
